Aurobindo Pharma receives USFDA Approval for Flucytosine Capsules Featured May 4, 2020 Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Flucytosine…
Aurobindo Pharma receives USFDA approval for Fluoxetine tablets Merger and Acquisition April 9, 2020 New Delhi: Aurobindo Pharma Limited is pleased to announce that the Company has received the final approval from the US…
Aurobindo Pharma’s $1 billion deal with Novartis unit Sandoz collapses Press Release April 2, 2020 Hyderabad: Aurobindo Pharma’s planned acquisition of the US generic oral solids and dermatology businesses of Sandoz Inc has fallen apart.…
